Jessica PyhtilainLazarus AIFDA Approves Combination Treatment for BPH SymptomsBy Jessica Pyhtila, PharmD, BCGP, BCPSMar 10, 2022Mar 10, 2022
Jessica PyhtilainLazarus AIFDA Approves New Orally Disintegrating Dosage Form of GlycopyrrolateBy Jessica Pyhtila, PharmD, BCGP, BCPSFeb 17, 2022Feb 17, 2022
Jessica PyhtilainLazarus AIFDA Approves Novel PCSK9 Inhibitor Inclisiran (Leqvio)By Jessica Pyhtila, PharmD, BCGP, BCPSJan 31, 2022Jan 31, 2022
Jessica PyhtilainLazarus AIFDA Approves Rivaroxaban in an Oral Suspension Dosage FormBy Jessica Pyhtila, PharmD, BCGP, BCPSDec 28, 2021Dec 28, 2021
Jessica PyhtilainLazarus AIFDA Approves Atogepant As Newest CGRP Antagonist for Migraine PreventionBy Jessica Pyhtila, PharmD, BCGP, BCPSOct 12, 2021Oct 12, 2021
Jessica PyhtilainLazarus AIFDA Approves Ergot-Derivative Nasal Spray to Treat Acute MigraineBy Jessica Pyhtila, PharmD, BCGP, BCPSOct 7, 2021Oct 7, 2021
Jessica PyhtilainLazarus AIFatal Opioid Overdoses Skyrocket During COVID-19 LockdownsThe CDC recently published an advisory stating that overdoses from synthetic opioids, generally fentanyl, and psychostimulants have…Oct 5, 2021Oct 5, 2021
Jessica PyhtilainLazarus AIScreening Colonoscopy Best Practices ReleasedBy Jessica Pyhtila, PharmD, BCGP, BCPSOct 1, 2021Oct 1, 2021
Jessica PyhtilainLazarus AIUsing Short and Long-Acting Insulin Together Does Not Increase Cardiovascular Events or MortalityBy Jessica Pyhtila, PharmD, BCGP, BCPSSep 29, 2021Sep 29, 2021
Jessica PyhtilainLazarus AITreatment Guidelines Released For Cancer PainBy Jessica Pyhtila, PharmD, BCGP, BCPSSep 27, 2021Sep 27, 2021